Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Repurposing FDA-approved drugs as a novel cancer therapeutic avenue through inhibition of PRMT5

Repurposing FDA-approved drugs as a novel cancer therapeutic avenue through inhibition of PRMT5

US Patent 12409173 · Granted Sep 9, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Electronic atomizing device2025
Electronic atomizing device2025
Self-adhesive waterproof coiled material of super-strong cross laminated film an2025
Loudspeaker2025
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors2025
Cable management device2024
Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors2024
Loudspeaker2024
Audio device2024
Loudspeaker2024
Loudspeaker2024
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors2024